Diffuse Hair Loss And Clinical Endocrinology: New Insights

    March 2013 in “ Journal für Kardiologie (Krause & Pachernegg GmbH) ”
    Jarmila Liptak, J Ring, W Chen
    Studysummary This review discusses the role of various hormones in diffuse hair loss and emphasizes the need for further research to clarify their complex interactions and potential therapeutic implications, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on kup.at →
    Discuss this study in the Community →

    Research cited in this study 38

    1. Androgenetic Alopecia and Insulin Resistance: Are They Truly Associated? International Journal of Dermatology · 2011
    2. The Investigation of Insulin Resistance and Metabolic Syndrome in Male Patients with Early-Onset Androgenetic Alopecia European Journal of Dermatology · 2011
    3. The Association of Insulin Resistance and Metabolic Syndrome in Early Androgenetic Alopecia PubMed · 2010
    4. Analysis of the Expression Pattern of the Carrier Protein Transthyretin and Its Receptor Megalin in the Human Scalp Skin and Hair Follicles: Hair Cycle-Associated Changes Histochemistry and cell biology · 2010
    5. Iron Deficiency in Female Pattern Hair Loss, Chronic Telogen Effluvium, and Control Groups Journal of The American Academy of Dermatology · 2010
    6. Androgenetic Alopecia and Cardiovascular Risk Factors in Men and Women: A Comparative Study Journal of The American Academy of Dermatology · 2010
    7. Association of Androgenetic Alopecia with Metabolic Syndrome in Men: A Community-Based Survey British Journal of Dermatology · 2010
    8. Influence of Melatonin on Hair Physiology Der Hautarzt · 2009
    9. Thyroid Receptor Agonists for the Treatment of Androgenetic Alopecia Bioorganic & Medicinal Chemistry Letters · 2009
    10. Thyrotropin Releasing Hormone: A New Player in Human Hair Growth Control ˜The œFASEB journal · 2009
    11. Leptin and the Skin: A New Frontier Experimental Dermatology · 2009
    12. Hormonal Basis of Male and Female Androgenic Alopecia: Clinical Relevance Skin Pharmacology and Physiology · 2009
    13. Is Androgenetic Alopecia a Risk for Atherosclerosis? Journal of The European Academy of Dermatology and Venereology · 2009
    14. Androgenetic Alopecia and Insulin Resistance in Young Men Clinical Endocrinology · 2008
    15. Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocrine reviews · 2008
    16. Evaluation of Lipid Levels in Androgenetic Alopecia Compared with Control Group Journal of The European Academy of Dermatology and Venereology · 2008
    17. Low Iron Stores: A Risk Factor for Excessive Hair Loss in Non-Menopausal Women PubMed · 2008
    18. No Association Between Serum Ferritin Levels Greater Than 10 μg/l and Hair Loss Activity in Women Dermatology · 2008
    19. Association of Androgenetic Alopecia and Hypertension PubMed · 2007
    20. Hair Follicle Expression of 1,25-Dihydroxyvitamin D3 Receptors During the Murine Hair Cycle British Journal of Dermatology · 2006
    21. Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, Which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression American Journal of Pathology · 2006
    22. The Role of Melatonin in Neuroectodermal-Mesodermal Interactions: The Hair Follicle Synthesizes Melatonin and Expresses Functional Melatonin Receptors ˜The œFASEB journal · 2005
    23. Melatonin Increases Anagen Hair Rate in Women With Androgenetic Alopecia or Diffuse Alopecia: Results of a Pilot Randomized Controlled Trial British Journal of Dermatology · 2004
    24. What May Be the Markers of the Male Equivalent of Polycystic Ovary Syndrome? Physiological Research · 2004
    25. Decreased Serum Ferritin Is Associated With Alopecia in Women Journal of Investigative Dermatology · 2003
    26. Prevalence of Polycystic Ovaries in Women with Androgenic Alopecia European journal of endocrinology · 2003
    27. Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2003
    28. There Is No Clear Association Between Low Serum Ferritin And Chronic Diffuse Telogen Hair Loss British Journal of Dermatology · 2002
    29. The Effect of Metformin on Hirsutism in Polycystic Ovary Syndrome European journal of endocrinology · 2002
    30. Lack of the Vitamin D Receptor Is Associated with Reduced Epidermal Differentiation and Hair Follicle Growth ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2002
    31. Human Follicular Papilla Cells Carry Out Non-Adipose Tissue Production of Leptin Journal of Investigative Dermatology · 2001
    32. Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study European journal of cardiovascular prevention & rehabilitation · 2001
    33. Early Androgenetic Alopecia as a Marker of Insulin Resistance The Lancet · 2000
    34. Does Tissue Iron Status Have a Role in Female Alopecia? Journal of The European Academy of Dermatology and Venereology · 1999
    35. The Risk of Coronary Heart Disease in Men with Androgenetic Alopecia Journal of The European Academy of Dermatology and Venereology · 1999
    36. Chronic Telogen Effluvium: Increased Scalp Hair Shedding in Middle-Aged Women Journal of The American Academy of Dermatology · 1996
    37. Hyperprolactinemia and Hypophyseal Hypothyroidism as Cofactors in Hirsutism and Androgen-Induced Alopecia in Women PubMed · 1991
    38. Biochemical and Trichological Characterization of Diffuse Alopecia in Women British Journal of Dermatology · 1990